TransCode Therapeutics(RNAZ) - 2021 Q4 - Earnings Call Transcript

TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Q4 2021 Earnings Conference Call April 7, 2022 4:30 PM ET Company Participants Alan Freidman - Vice President, Investor Relations Michael Dudley - Co-Founder, Chief Executive Officer, and Director Thomas Fitzgerald - Vice President and Chief Financial Officer Zdravka Medarova - Chief Technology Officer Conference Call Participants Operator Hello, thank you for standing by and welcome to the TransCode Therapeutics Conference Call. At this time, all participants are ...